Clinical Trial Update: Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing AEB071 vs tacrolimus with mycophenolate, basiliximab and steroids for acute rejection prevention in kidney transplantation; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• AEB071 (sotrastaurin)
• Basiliximab (basiliximab)
• Mycophenolate acid sodium (mycophenolate mofetil)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: COMPLETED